These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27055203)

  • 41. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
    Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
    J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exacerbations of COPD.
    Pavord ID; Jones PW; Burgel PR; Rabe KF
    Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):21-30. PubMed ID: 26937187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
    Decramer M; Dahl R; Kornmann O; Korn S; Lawrence D; McBryan D
    Respir Med; 2013 Feb; 107(2):223-32. PubMed ID: 23219347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
    Leshchenko IV
    Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute exacerbations of chronic obstructive pulmonary disease in the emergency department.
    Brulotte CA; Lang ES
    Emerg Med Clin North Am; 2012 May; 30(2):223-47, vii. PubMed ID: 22487106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.
    Crim C; Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Willits LR; Yates JC; Vestbo J
    Eur Respir J; 2009 Sep; 34(3):641-7. PubMed ID: 19443528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing acute respiratory failure during exacerbation of chronic obstructive pulmonary disease.
    Schumaker GL; Epstein SK
    Respir Care; 2004 Jul; 49(7):766-82. PubMed ID: 15222909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.
    Wilson R; Sethi S; Anzueto A; Miravitlles M
    J Infect; 2013 Dec; 67(6):497-515. PubMed ID: 23973659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence?
    Ferguson GT
    Respir Med; 2011 Sep; 105(9):1268-74. PubMed ID: 21353516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
    Jones D
    N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of exacerbations: how are we doing and can we do better?
    Burge PS
    Proc Am Thorac Soc; 2006 May; 3(3):257-61. PubMed ID: 16636095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
    Daniels JM; Snijders D; de Graaff CS; Vlaspolder F; Jansen HM; Boersma WG
    Am J Respir Crit Care Med; 2010 Jan; 181(2):150-7. PubMed ID: 19875685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
    Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.
    Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR;
    S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations.
    Haja Mydin H; Murphy S; Antunes G
    Thorax; 2012 Jan; 67(1):82; author reply 82-3. PubMed ID: 21386106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.